z-logo
open-access-imgOpen Access
Pharmacologic Treatment of Cancer: New Developments
Author(s) -
William S. Dalton
Publication year - 1999
Publication title -
cancer control
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.794
H-Index - 72
eISSN - 1526-2359
pISSN - 1073-2748
DOI - 10.1177/107327489900600511
Subject(s) - medicine , cancer , cancer treatment , intensive care medicine
In this issue of Cancer Control, five reviews address the current state of the art for the pharmacologic treatment of cancer. For centuries, surgery was considered the only curative treatment for cancer. Likewise, radiation therapy offered some patients a possible cure for cancers that were localized. However, once the disease spread from its original site of origin, the patient was deemed inoperable and therefore incurable. This self-fulfilling prophecy remained true until the development of systemic therapy that addressed not only localized disease, but also disease that had spread to distant sites. Cytotoxic drugs represent the most commonly used treatment for cancers that have metastasized, although hormones can have a major impact in diseases such as breast and prostate cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom